431 related articles for article (PubMed ID: 19183407)
1. AKR-501 (YM477) a novel orally-active thrombopoietin receptor agonist.
Fukushima-Shintani M; Suzuki K; Iwatsuki Y; Abe M; Sugasawa K; Hirayama F; Kawasaki T; Nakahata T
Eur J Haematol; 2009 Apr; 82(4):247-54. PubMed ID: 19183407
[TBL] [Abstract][Full Text] [Related]
2. AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis.
Fukushima-Shintani M; Suzuki K; Iwatsuki Y; Abe M; Sugasawa K; Hirayama F; Kawasaki T
Exp Hematol; 2008 Oct; 36(10):1337-42. PubMed ID: 18619724
[TBL] [Abstract][Full Text] [Related]
3. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
4. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL.
Nishino T; Miyaji K; Ishiwata N; Arai K; Yui M; Asai Y; Nakauchi H; Iwama A
Exp Hematol; 2009 Nov; 37(11):1364-1377.e4. PubMed ID: 19744539
[TBL] [Abstract][Full Text] [Related]
6. Efficient assay for evaluating human thrombopoiesis using NOD/SCID mice transplanted with cord blood CD34+ cells.
Suzuki K; Hiramatsu H; Fukushima-Shintani M; Heike T; Nakahata T
Eur J Haematol; 2007 Feb; 78(2):123-30. PubMed ID: 17087740
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological profile of AS1670542, a novel orally-active human thrombopoietin receptor agonist.
Abe M; Suzuki K; Sakata C; Sugasawa K; Hirayama F; Koga Y; Kawasaki T; Naganuma S; Itoh H
Eur J Pharmacol; 2011 Jan; 650(1):58-63. PubMed ID: 20950606
[TBL] [Abstract][Full Text] [Related]
8. Thrombopoietin (Mpl ligand) and the regulation of platelet production.
Cohen-Solal K; Debili N; Vainchenker W; Wendling F
Eur Cytokine Netw; 1997 Sep; 8(3):311-4. PubMed ID: 9346371
[No Abstract] [Full Text] [Related]
9. An effective and simple expansion system for megakaryocyte progenitor cells using a combination of heparin with thrombopoietin and interleukin-11.
Feng Y; Zhang L; Xiao ZJ; Li B; Liu B; Fan CG; Yuan XF; Han ZC
Exp Hematol; 2005 Dec; 33(12):1537-43. PubMed ID: 16338497
[TBL] [Abstract][Full Text] [Related]
10. [In vitro expansion of cord blood megakaryocyte progenitor].
Feng Y; Xiao ZJ; Xu SC; Lu SH; Liu B; Liu JH; Han ZC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Apr; 27(2):199-204. PubMed ID: 15960266
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo culture of human CD34+ cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse model.
van Hensbergen Y; Schipper LF; Brand A; Slot MC; Welling M; Nauta AJ; Fibbe WE
Exp Hematol; 2006 Jul; 34(7):943-50. PubMed ID: 16797422
[TBL] [Abstract][Full Text] [Related]
12. Adenovector-mediated expression of human thrombopoietin cDNA in immune-compromised mice: insights into the pathophysiology of osteomyelofibrosis.
Frey BM; Rafii S; Teterson M; Eaton D; Crystal RG; Moore MA
J Immunol; 1998 Jan; 160(2):691-9. PubMed ID: 9551904
[TBL] [Abstract][Full Text] [Related]
13. Physiologic role of TPO in thrombopoiesis.
Miyazaki H
Stem Cells; 1996; 14 Suppl 1():133-8. PubMed ID: 11012213
[TBL] [Abstract][Full Text] [Related]
14. Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice.
Grossmann A; Lenox J; Ren HP; Humes JM; Forstrom JW; Kaushansky K; Sprugel KH
Exp Hematol; 1996 Aug; 24(10):1238-46. PubMed ID: 8765500
[TBL] [Abstract][Full Text] [Related]
15. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure.
Chen TW; Hwang SM; Chu IM; Hsu SC; Hsieh TB; Yao CL
Exp Hematol; 2009 Nov; 37(11):1330-1339.e5. PubMed ID: 19664680
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
Newland A
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
[TBL] [Abstract][Full Text] [Related]
17. Effects of Mpl ligands on platelet production and function in nonhuman primates.
Harker LA; Marzec UM; Kelly AB
Stem Cells; 1998; 16 Suppl 2():107-19. PubMed ID: 11012183
[TBL] [Abstract][Full Text] [Related]
18. [Clinical use of recombinant human thrombopoietin. Status and perspectives].
Hansen PB; Hasselbalch HC
Ugeskr Laeger; 2001 May; 163(19):2659-62. PubMed ID: 11360368
[TBL] [Abstract][Full Text] [Related]
19. Milestones in understanding platelet production: a historical overview.
Kuter DJ
Br J Haematol; 2014 Apr; 165(2):248-58. PubMed ID: 24528208
[TBL] [Abstract][Full Text] [Related]
20. [Biology of thrombopoietin and its receptors].
Robak T
Postepy Hig Med Dosw; 1996; 50(6):649-63. PubMed ID: 9064684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
